Duquesne Family Office LLC filed Q1 2026 13F: NTRA leads a $3.4M portfolio

Filed: 2026-05-15 · Report date: 2026-03-31 · Form: 13F-HR

Source: SEC EDGAR filing

Portfolio overview

Portfolio value: $3.4M
Holdings: 70
Previous quarter: 2025-12-31

Top 5 holdings

NTRA — $612.7K (18.1%)
INSM — $188.7K (5.6%)
TSM — $167.4K (5.0%)
IAU — $162.3K (4.8%)
RSP — $157.6K (4.7%)

New positions

AVGO — $60.7K (1.8%)
Global X Fds — $36.2K (1.1%)
CAI — $33.9K (1.0%)
RVMD — $30.7K (0.91%)
SNDK — $24.2K (0.72%)

Exits

XLF — last seen at $301K
GOOGL — last seen at $120.5K
Cogent Biosciences Inc — last seen at $78.7K
Entegris Inc — last seen at $71.1K
Docusign Inc — last seen at $69.7K

Biggest adds

YPF — +$127.6K (now $149.6K)
STM — +$70.2K (now $90.3K)
IAU — +$49.4K (now $162.3K)

Biggest trims

Teva Pharmaceutical Inds Ltd — -$111.8K (now $71.6K)
CPNG — -$109.4K (now $50.4K)
WWD — -$103K (now $75.6K)

Methodology note

13F filings are public quarterly disclosures with up to a 45-day lag from quarter-end. Numbers here reflect the manager's disclosed long US equity positions only; they are not a real-time portfolio, do not include derivatives or short positions, and are not actual fund NAV. Not investment advice.

Full case file: https://worldsmartmoney.com/manager/duquesne

This article: https://worldsmartmoney.com/news/duquesne-2026-03-31-000004

English thread

Tweet 1/5 · 164 chars

Duquesne Family Office LLC filed Q1 2026 13F.

Portfolio: $3.4M (70 holdings)
Top: NTRA $612.7K (18.1%)

https://worldsmartmoney.com/news/duquesne-2026-03-31-000004

Tweet 2/5 · 129 chars

Top 5 holdings:

1. NTRA $612.7K (18.1%)
2. INSM $188.7K (5.6%)
3. TSM $167.4K (5.0%)
4. IAU $162.3K (4.8%)
5. RSP $157.6K (4.7%)

Tweet 3/5 · 132 chars

Position changes from 2025-12-31:

🆕 New: AVGO, Global X Fds, CAI, RVMD
🚪 Exited: XLF, GOOGL, Cogent Biosciences Inc, Entegris Inc

Tweet 4/5 · 147 chars

📈 Biggest adds:
  YPF +$127.6K
  STM +$70.2K
  IAU +$49.4K

📉 Biggest trims:
  Teva Pharmaceutical Inds Ltd -$111.8K
  CPNG -$109.4K
  WWD -$103K

Tweet 5/5 · 239 chars

Source: SEC 13F (≤45-day disclosure lag, not real-time, not fund NAV).

SEC: https://www.sec.gov/Archives/edgar/data/1536411/000153641126000004/0001536411-26-000004-index.htm
WSM: https://worldsmartmoney.com/news/duquesne-2026-03-31-000004

Chinese thread

Tweet 1/5 · 145 chars

Duquesne Family Office LLC 更新 2026 Q1 13F

组合：$3.4M（70 只持仓）
第一持仓：NTRA $612.7K（18.1%）

https://worldsmartmoney.com/news/duquesne-2026-03-31-000004

Tweet 2/5 · 117 chars

前 5 大持仓：

1. NTRA $612.7K（18.1%）
2. INSM $188.7K（5.6%）
3. TSM $167.4K（5.0%）
4. IAU $162.3K（4.8%）
5. RSP $157.6K（4.7%）

Tweet 3/5 · 105 chars

相比 2025-12-31 的变化：

🆕 新建仓：AVGO、Global X Fds、CAI、RVMD
🚪 清仓：XLF、GOOGL、Cogent Biosciences Inc、Entegris Inc

Tweet 4/5 · 130 chars

📈 加仓最多：
  YPF +$127.6K
  STM +$70.2K
  IAU +$49.4K

📉 减仓最多：
  Teva Pharmaceutical Inds Ltd -$111.8K
  CPNG -$109.4K
  WWD -$103K

Tweet 5/5 · 208 chars

来源：SEC 13F（最多滞后 45 天公开，非实时，不代表基金净值）

SEC 原文：https://www.sec.gov/Archives/edgar/data/1536411/000153641126000004/0001536411-26-000004-index.htm
WSM 解读：https://worldsmartmoney.com/news/duquesne-2026-03-31-000004

13F is a quarterly disclosure with up to 45-day lag. Not real-time, not fund NAV, not investment advice.